ÂÜÀòÂÒÂ×

Kathryn Hush-Munoz has extensive experience in the field of health economics and outcomes research, as well as medical affairs programs. Kathryn served as a Senior Director of Health Economics and Outcomes Research at Avidity Biosciences since April 2021. Before that, Kathryn worked at Ipsen from January 2019 to April 2021, where they held roles as a Medical Director for Rare Disease and as the HEOR Director for Oncology and Rare Disease. Kathryn was responsible for developing strategies and executing medical affairs programs, including real-world evidence (RWE) and ensuring payer coverage for rare disease products.

Prior to their time at Ipsen, Kathryn worked at Sanofi Genzyme from June 2014 to December 2019, where they held the positions of Medical Managed Care Director and Health Economics and Value Assessment Field Director. Kathryn also had experience in health quality and outcomes as a Health Quality and Outcomes Liaison at Optimer Pharmaceuticals from January 2013 to December 2013.

Earlier in their career, Kathryn worked as a Distinguished Medical Science Liaison in Oncology at Eisai from 2008 to 2013. Kathryn also held various roles at Pathwork Diagnostics, Novacea, and Abbott, where they gained experience in medical science, managed care liaison, and oncology clinical science management.

Overall, Kathryn Hush-Munoz's work experience demonstrates their expertise in health economics and outcomes research, medical affairs programs, and managed care liaison in the pharmaceutical industry.

Kathryn Hush-Munoz has an extensive education history. Kathryn obtained their Bachelor of Science degree in Nutrition and Food Science from the University of Arizona. Following this, they went on to pursue a Master of Science degree in Clinical Nutrition and Exercise Sciences also at the University of Arizona. Kathryn then completed their Doctor of Philosophy (Ph.D.) in Biochemistry and Statistics, again at the University of Arizona. Lastly, they obtained a Master of Public Health (MPH) degree from the University of North Carolina at Chapel Hill.